Departments

Department of Medical Microbiology and Parasitology

来源 : admin     发布时间 :2011-06-25    浏览次数 :2884

 

Basic Information  
The department of medical microbiology and parasitology at College of Medicine, Zhejiang University, has nine faculties, including two professors / PhD and MD supervisors, four associate professors / master supervisors, one associate professor and two lecturers. Seven of the department personnel own a doctorate degree; two master degree holders are currently working for their doctorate degrees. Two teachers received Special National Government Allowance of China, and one teacher received Top Talents Award of the Zhejiang New Century Project. In addition, one professor/ PhD supervisor and one associate professor/ master supervisor are being recruited.  

Featured Research
In the recent years, the department is responsible for fifteen research grants funded by the National Natural Science Foundation of China, one sub-grant under National Infectious Diseases Special Project, and one German National Science Exchange grant (provincial and ministerial research projects are not introduced). There are three principle investigator (PI) research teams, currently working on zoonotic pathogenesis and development of new vaccines, anti-infection immune mechanisms, and respiratory tract microbial pathogenesis, respectively. The department has Division of Basic Medical Microbiology that belongs to Chinese State Key Laboratory for Diagnosis and Treatment of Infectious Diseases.

Teaching Characteristics 
For Chinese students, undergraduate courses include medical microbiology and medical parasitology, and graduate courses include current medical microbiology, current medical parasitology, cell culture techniques and special issues on biology of pathogens. Courses for international students include medical microbiology and medical parasitology.

Directions of Graduate Education 
a) Pathogenesis of zoonosis, molecular and cellular basis underlying host-zoonotic pathogen interactions; b) Genetically engineered vaccines and novel drugs for clinically important pathogens; c) Molecular and cellular mechanisms of mucosal anti-infection immunity; d) Respiratory tract microbial pathogenesis, signal transduction and drug-screening for drug resistant bacterium.